{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:56:53Z","timestamp":1771538213564,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s1470-2045(14)71016-2","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T20:00:57Z","timestamp":1422475257000},"page":"e60-e70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":341,"title":["Familial gastric cancer: genetic susceptibility, pathology, and implications for management"],"prefix":"10.1016","volume":"16","author":[{"given":"Carla","family":"Oliveira","sequence":"first","affiliation":[]},{"given":"Hugo","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Carneiro","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(14)71016-2_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"suppl 1","key":"10.1016\/S1470-2045(14)71016-2_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10120-002-0203-6","article-title":"The epidemiology of gastric cancer","volume":"5","author":"Roder","year":"2002","journal-title":"Gastric Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I","article-title":"Family history and the risk of stomach and colorectal cancer","volume":"70","author":"La Vecchia","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":"E-cadherin germline mutations in familial gastric cancer","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1470-2045(14)71016-2_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/path.4152","article-title":"An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer","volume":"229","author":"Majewski","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/B978-0-12-394311-8.00015-7","article-title":"E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer","volume":"116","author":"Oliveira","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/S1470-2045(14)71016-2_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1399-0004.2011.01744.x","article-title":"De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer","volume":"82","author":"Shah","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","article-title":"Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research","volume":"47","author":"Fitzgerald","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jmg.2005.031385","article-title":"Cleft lip\/palate and CDH1\/E-cadherin mutations in families with hereditary diffuse gastric cancer","volume":"43","author":"Frebourg","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.26398","article-title":"CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling","volume":"131","author":"Kluijt","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S1470-2045(14)71016-2_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/gutjnl-2011-300348","article-title":"Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome","volume":"61","author":"Worthley","year":"2012","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/gutjnl-2011-301384","article-title":"Familial fundic gland polyposis with gastric cancer","volume":"61","author":"Yanaru-Fujisawa","year":"2012","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jmg.36.12.873","article-title":"Familial gastric cancer: overview and guidelines for management","volume":"36","author":"Caldas","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib16","doi-asserted-by":"crossref","first-page":"385132","DOI":"10.1155\/2013\/385132","article-title":"History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family","volume":"2013","author":"Corso","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/S1470-2045(14)71016-2_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2012.164","article-title":"Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM)\u2014update 2012","volume":"21","author":"Rahner","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.gastro.2009.10.051","article-title":"Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands","volume":"138","author":"Capelle","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/S1470-2045(14)71016-2_bib19","first-page":"1365","article-title":"Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome","volume":"43","author":"Li","year":"1969","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(14)71016-2_bib20","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1016\/S1470-2045(14)71016-2_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","article-title":"The IARC TP53 database: new online mutation analysis and recommendations to users","volume":"19","author":"Olivier","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/S1470-2045(14)71016-2_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/GIM.0b013e31821628b6","article-title":"Gastric cancer in individuals with Li-Fraumeni syndrome","volume":"13","author":"Masciari","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/S1470-2045(14)71016-2_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10689-005-5673-3","article-title":"The genetics of FAP and FAP-like syndromes","volume":"5","author":"Lipton","year":"2006","journal-title":"Fam Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2007.136127","article-title":"Guidelines for the clinical management of familial adenomatous polyposis (FAP)","volume":"57","author":"Vasen","year":"2008","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(89)90840-4","article-title":"Upper gastrointestinal cancer in patients with familial adenomatous polyposis","volume":"334","author":"Spigelman","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jso.20214","article-title":"Gastric cancer: new genetic developments","volume":"90","author":"Lynch","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/his.12393","article-title":"Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps","author":"Arnason","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/S1470-2045(14)71016-2_bib28","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/1097-0142(19951215)76:12<2427::AID-CNCR2820761205>3.0.CO;2-B","article-title":"Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP","volume":"76","author":"Lynch","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib29","first-page":"667","article-title":"Upper gastrointestinal polyps in familial adenomatous polyposis","volume":"46","author":"Offerhaus","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/S1470-2045(14)71016-2_bib30","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.2008.16.7056","article-title":"Total gastrectomy for gastric dysplasia in a patient with attenuated familial adenomatous polyposis syndrome","volume":"26","author":"Ong","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib31","first-page":"71","article-title":"Peutz-Jeghers syndrome: its natural course and management","volume":"136","author":"Utsunomiya","year":"1975","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/S1470-2045(14)71016-2_bib32","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"Van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gut.2010.223750","article-title":"High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome","volume":"60","author":"Van Lier","year":"2011","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1521-6918(02)00149-X","article-title":"Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer","volume":"17","author":"Allen","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jmg.2004.018598","article-title":"The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations","volume":"41","author":"Howe","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib36","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Breast Cancer Linkage","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(14)71016-2_bib37","first-page":"60","article-title":"BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian","volume":"7","author":"Friedenson","year":"2005","journal-title":"Med Gen Med"},{"key":"10.1016\/S1470-2045(14)71016-2_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.ejhg.5201064","article-title":"A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer","volume":"11","author":"Jakubowska","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib39","first-page":"4086","article-title":"Identification of germ-line E-cadherin mutations in gastric cancer families of European origin","volume":"58","author":"Gayther","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(14)71016-2_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/8.4.607","article-title":"Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer","volume":"8","author":"Richards","year":"1999","journal-title":"Hum Mol Gen"},{"key":"10.1016\/S1470-2045(14)71016-2_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9","article-title":"E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer","volume":"14","author":"Guilford","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/S1470-2045(14)71016-2_bib42","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","article-title":"Germline CDH1 deletions in hereditary diffuse gastric cancer families","volume":"18","author":"Oliveira","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/ddg048","article-title":"Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands","volume":"12","author":"Suriano","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2003.022061","article-title":"Clinical implications of E-cadherin associated hereditary diffuse gastric cancer","volume":"53","author":"Fitzgerald","year":"2004","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00109-006-0091-z","article-title":"A model to infer the pathogenic significance of CDH1 germline missense variants","volume":"84","author":"Suriano","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/S1470-2045(14)71016-2_bib46","doi-asserted-by":"crossref","first-page":"e33783","DOI":"10.1371\/journal.pone.0033783","article-title":"E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer","volume":"7","author":"Simoes-Correia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S1470-2045(14)71016-2_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejhg.2012.159","article-title":"The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC","volume":"21","author":"Figueiredo","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1109\/TIP.2010.2055879","article-title":"Convex total variation denoising of Poisson fluorescence confocal images with anisotropic filtering","volume":"20","author":"Rodrigues","year":"2011","journal-title":"IEEE Trans Image Process"},{"key":"10.1016\/S1470-2045(14)71016-2_bib49","article-title":"Quantification of mutant E-cadherin using bioimaging analysis of in-situ fluorescence microscopy. A new approach to CDH1 missense mutants","author":"Sanches","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.2415","article-title":"Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk","volume":"216","author":"Barber","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib51","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/ddp537","article-title":"Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer","volume":"19","author":"Pinheiro","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/gcc.22155","article-title":"Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome","volume":"53","author":"Molinaro","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib53","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":"Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression","volume":"136","author":"Oliveira","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/S1470-2045(14)71016-2_bib54","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1200\/JCO.2012.44.4612","article-title":"Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer","volume":"31","author":"Corso","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib55","doi-asserted-by":"crossref","first-page":"e1004669","DOI":"10.1371\/journal.pgen.1004669","article-title":"Germline mutations in MAP3K6 are associated with familial gastric cancer","volume":"10","author":"Gaston","year":"2014","journal-title":"PLoS Genet"},{"issue":"suppl 1","key":"10.1016\/S1470-2045(14)71016-2_bib56","first-page":"249","article-title":"Unraveling the genetic predisposition of early-onset and familial gastric cancer","volume":"22","author":"Hoogerbrugge","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/79120","article-title":"Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer","volume":"26","author":"Grady","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib58","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.onc.1207335","article-title":"Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour","volume":"23","author":"Oliveira","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/S1470-2045(14)71016-2_bib59","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/path.2426","article-title":"Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer","volume":"216","author":"Barber","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/path.1564","article-title":"Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening","volume":"203","author":"Carneiro","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib61","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-06-3021","article-title":"Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer","volume":"67","author":"Humar","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(14)71016-2_bib62","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gut.2002.010447","article-title":"Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone","volume":"53","author":"Charlton","year":"2004","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib63","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31815e7f1a","article-title":"Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications","volume":"32","author":"Rogers","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/gut.2004.049171","article-title":"Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?","volume":"54","author":"Shaw","year":"2005","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib65","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJM200106213442504","article-title":"Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations","volume":"344","author":"Huntsman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(14)71016-2_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gie.2013.11.040","article-title":"Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance","volume":"80","author":"Lim","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/S1470-2045(14)71016-2_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2012.247","article-title":"Clinical utility gene card for: hereditary diffuse gastric cancer (HDGC)","volume":"21","author":"Oliveira","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10689-009-9316-y","article-title":"Pregnancy after prophylactic total gastrectomy","volume":"9","author":"Kaurah","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1016\/S1470-2045(14)71016-2_bib69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molmed.2012.09.004","article-title":"Cancer syndromes and therapy by stop-codon readthrough","volume":"18","author":"Bordeira-Carrico","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/S1470-2045(14)71016-2_bib70","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/ejhg.2013.292","article-title":"Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA","volume":"22","author":"Bordeira-Carrico","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib71","doi-asserted-by":"crossref","first-page":"e23188","DOI":"10.1371\/journal.pone.0023188","article-title":"ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones","volume":"6","author":"Figueiredo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S1470-2045(14)71016-2_bib72","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/nar\/gkt1019","article-title":"Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter","volume":"42","author":"Chen","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S1470-2045(14)71016-2_bib73","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00432-010-0849-0","article-title":"Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells","volume":"136","author":"Chang","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1083\/jcb.200208156","article-title":"Direct cadherin-activated cell signaling: a view from the plasma membrane","volume":"160","author":"Yap","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/S1470-2045(14)71016-2_bib75","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature04872","article-title":"New signals from the invasive front","volume":"441","author":"Christofori","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S1470-2045(14)71016-2_bib76","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/ddm113","article-title":"EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells","volume":"16","author":"Mateus","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1470-2045(14)71016-2_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3904\/kjim.2013.28.2.149","article-title":"Molecular targeted therapy for advanced gastric cancer","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/S1470-2045(14)71016-2_bib78","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1517\/14728222.2013.827174","article-title":"Therapeutic targets associated to E-cadherin dysfunction in gastric cancer","volume":"17","author":"Carneiro","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/S1470-2045(14)71016-2_bib79","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.febslet.2012.07.045","article-title":"E-cadherin dysfunction in gastric cancer\u2014cellular consequences, clinical applications and open questions","volume":"586","author":"Carneiro","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/S1470-2045(14)71016-2_bib80","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1158\/0008-5472.CAN-08-2457","article-title":"E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man","volume":"69","author":"Humar","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(14)71016-2_bib81","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1349-7006.2011.01890.x","article-title":"Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer","volume":"102","author":"Mimata","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/S1470-2045(14)71016-2_bib82","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gutjnl-2011-300050","article-title":"Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer","volume":"61","author":"Shimada","year":"2012","journal-title":"Gut"},{"key":"10.1016\/S1470-2045(14)71016-2_bib83","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1073\/pnas.92.3.855","article-title":"A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development","volume":"92","author":"Riethmacher","year":"1995","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204514710162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204514710162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:14:17Z","timestamp":1761459257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204514710162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1470204514710162"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(14)71016-2","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial gastric cancer: genetic susceptibility, pathology, and implications for management","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(14)71016-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}